Stay updated with breaking news from Mintz Life Sciences Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mintz represented Axoft, a neurotechnology company, in its $8 million seed round led by The Engine, a venture firm spun out of MIT that invests in early-stage Tough Tech companies.
Mintz served as legal counsel to ProKidney LP, a leading clinical-stage cellular therapeutics company focused on chronic kidney disease, in its combination with Social Capital Suvretta Holdings Corp. III, a special purpose acquisition company (SPAC), and its subsequent listing on the Nasdaq.